Gnanasakthy, A., & DeMuro, C. (2016). OUTCOME ASSESSMENTS OF PRIMARY ENDPOINTS OF NEW DRUGS APPROVED BY THE FDA (2011-2015). Value in Health, 19(3), A275. https://doi.org/10.1016/j.jval.2016.03.1962
studies of recent FDA approvals. PROs were key to assess treatment benefit in diseases such as those related to genitourinary, digestive and musculoskeletal systems as per respective regulatory guidance.
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.